4
Changes in Ownership
IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001250853-14-000142
Options or other derivatives
- Chief Financial Officer acquired 40,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Handelman Michael D · Chief Financial Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2014-12-05 | Grant or award : show line 1 in the form Stock Option (right to buy) | +40,000 | $6.25 | 2024-12-04 | 40,000 | 40,000 | D |
Loading xslF345X03/primary_doc.xml…